Author

Manini S. Penikalapati

National Cancer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Jordan L. MeieriD· 2 shared Aldema Sas‐CheniD· 1 shared Anver Basha ShaikiD· 1 shared Brett W. BurkhartiD· 1 shared Courtney N. LinkiD· 1 shared Isita JhulkiiD· 1 shared Jane E. Jones· 1 shared Joycelyn H. Williams· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Jordan L. MeierORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistryNucleic Acids ResearchPeer-reviewedMar 7, 2025

A sequence-specific RNA acetylation catalyst

Supuni Thalalla Gamage, Shereen A. Howpay Manage, Aldema Sas‐Chen…·Jordan L. Meier

This study characterizes TkNat10, an RNA acetyltransferase from T. kodakarensis, showing its role in thermotolerance and its ability to modify RNA substrates with specific sequence preferences.

7 citations

experimental assay

𝕏 PostBluesky

BiochemistryJACS AuPeer-reviewedJul 29, 2024

Paralogue-selective degradation of the lysine acetyltransferase EP300

Xuemin Chen, McKenna C. Crawford, Ying Xiong…·Jordan L. Meier

This study develops a small molecule, MC-1, that selectively degrades EP300 over CREBBP, revealing factors governing paralogue-specific degradation and its impact on cancer cell proliferation.

12 citations

humanproteomics

𝕏 PostBluesky